News
Eli Lilly CEO Dave Ricks took a stand against Trump's tariffs in a Q1 earnings call. The medicine company has strong operations for obesity and weight loss drugs in Ireland.
Eli Lilly and Co. will break ground on its $4.5 billion Lilly Medicine Foundry in Lebanon, Indiana's LEAP Research and ...
Adam Lowry’s voice broke when he heard Rick Bowness’ voice on the other end of the line. Speaking on TNT after scoring the ...
Eli Lilly (LLY) is among the list of large-cap pharmaceutical companies that are awaiting the Trump administration's word on ...
David Adelman became the Nuggets' interim head coach three games before the regular season ended. He has managed a difficult ...
Ricks said reshoring manufacturing capacity for older essential medicines is “a valid thing,” adding that Eli Lilly is “happy ...
Eli Lilly CEO Dave Ricks urged the Trump administration to move fast on foreign trade deals and warned of the harmful effects retaliatory tariffs could have on American exporters like Eli Lilly.
To say, as CEO David Ricks did, that this was a good quarter, is an understatement. Mounjaro in diabetes brought in $3.84 ...
As residents call the number of building permits issued in the Palisades too low, will artificial intelligence speed up the ...
Eli Lilly CEO David Ricks is confident that weight loss med Zepbound is gaining market share at the expense of Wegovy, even as its rival strikes deals with CVS and Hims & Hers pharmacies.
Wegovy was first to market but has been losing ground to Eli Lilly's Zepbound in recent months, according to the latest ...
Take Eli Lilly helmsman Dave Ricks, for example. Despite the Indianapolis pharma making a $27 billion U.S. production pledge in late February, Ricks took his company’s first-quarter earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results